StockData
BioNTech SE logo

BioNTech SE (BNTX) stock

BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30
$85.60+0.56 (+0.66%)

Close on Nov 13, 2026Market cap $21.50BP/E –Yield –

BioNTech gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 77.6%, against 80.3% the year before. The highest annual figure on record is 89.3% in fiscal 2018.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202577.6%−2.7
FY2024Dec 31, 202480.3%−4.0
FY2023Dec 31, 202384.3%+1.6
FY2022Dec 31, 202282.7%−2.0
FY2021Dec 31, 202184.7%−3.0
FY2020Dec 31, 202087.7%+3.7
FY2019Dec 31, 201984.0%−5.3
FY2018Dec 31, 201889.3%+4.4
FY2017Dec 31, 201784.9%–

More BioNTech figures

See a number that looks wrong?